n this poignant episode, USA Today investigative journalist Emily Le Coz unravels the heart-wrenching narrative of Ashleigh Anderson, a CVS pharmacist whose tragic demise serves as a cautionary tale of overwhelming stress in the workplace.
Emily shares her motivations behind delving into the pervasive issue of burnout in retail pharmacy and sheds light on the very real threat it poses. She recounts the details of the Ashleigh Anderson story, where the toxic culture within retail pharmacy played a pivotal role in a life lost to the pressures of the job. Together, we navigate the profound implications of burnout, exploring its dangers and the urgent need for systemic change within the retail pharmacy landscape. This episode serves as both a tribute to Ashleigh Anderson and a rallying cry for reform in an industry grappling with the devastating consequences of unchecked workplace stress.
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
